Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of SHREE GANESH REMEDIES . For more details, see the SHREE GANESH REMEDIES quarterly results and SHREE GANESH REMEDIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 4.2 |
No. of shares | m | 12.85 |
1 Week | % | -8.6 |
1 Month | % | -12.1 |
1 Year | % | 98.3 |
52 week H/L | Rs | 736.0/282.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SHREE GANESH REMEDIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 76 | 111 | 345 | 503 | 349 | |
Low | Rs | 42 | 54 | 65 | 227 | 213 | |
Sales per share (Unadj.) | Rs | 39.4 | 71.4 | 49.0 | 59.4 | 70.2 | |
Earnings per share (Unadj.) | Rs | 7.0 | 11.7 | 9.7 | 11.2 | 13.2 | |
Diluted earnings per share | Rs | 4.9 | 8.2 | 7.6 | 10.4 | 13.2 | |
Cash flow per share (Unadj.) | Rs | 8.1 | 14.2 | 12.5 | 13.9 | 16.1 | |
Dividends per share (Unadj.) | Rs | 1.25 | 1.50 | 1.75 | 0.50 | 0.50 | |
Adj. dividends per share | Rs | 0.87 | 1.05 | 1.36 | 0.47 | 0.50 | |
Avg Dividend yield | % | 2.1 | 1.8 | 0.9 | 0.1 | 0.2 | |
Book value per share (Unadj.) | Rs | 37.7 | 47.0 | 50.0 | 51.3 | 69.2 | |
Adj. book value per share | Rs | 26.3 | 32.8 | 38.9 | 47.9 | 69.2 | |
Shares outstanding (eoy) | m | 8.97 | 8.97 | 10.01 | 12.01 | 12.85 | |
Price / Sales ratio | x | 1.5 | 1.2 | 4.2 | 6.1 | 4.0 | |
Avg P/E ratio | x | 8.5 | 7.1 | 21.0 | 32.7 | 21.2 | |
P/CF ratio (eoy) | x | 7.3 | 5.8 | 16.4 | 26.2 | 17.4 | |
Price / Book Value ratio | x | 1.6 | 1.8 | 4.1 | 7.1 | 4.1 | |
Dividend payout | % | 18.0 | 12.9 | 18.0 | 4.5 | 3.8 | |
Avg Mkt Cap | Rs m | 530 | 740 | 2,051 | 4,383 | 3,611 | |
Total wages/salary | Rs m | 16 | 29 | 24 | 30 | 39 |
SHREE GANESH REMEDIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 353 | 640 | 491 | 713 | 902 | |
Other income | Rs m | 12 | 39 | 21 | 36 | 32 | |
Total revenues | Rs m | 365 | 679 | 512 | 749 | 934 | |
Gross profit | Rs m | 87 | 125 | 136 | 179 | 233 | |
Depreciation | Rs m | 10 | 23 | 27 | 33 | 37 | |
Interest | Rs m | 2 | 5 | 1 | 1 | 1 | |
Profit before tax | Rs m | 87 | 136 | 130 | 180 | 226 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 24 | 31 | 32 | 46 | 56 | |
Profit after tax | Rs m | 62 | 105 | 98 | 134 | 170 | |
Gross profit margin | % | 24.8 | 19.6 | 27.8 | 25.1 | 25.8 | |
Effective tax rate | % | 28.1 | 23.0 | 24.7 | 25.6 | 24.6 | |
Net profit margin | % | 17.7 | 16.4 | 19.9 | 18.8 | 18.9 |
SHREE GANESH REMEDIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 258 | 338 | 380 | 449 | 643 | |
Current liabilities | Rs m | 68 | 104 | 102 | 150 | 237 | |
Net working cap to sales | % | 53.9 | 36.6 | 56.7 | 41.9 | 44.9 | |
Current ratio | x | 3.8 | 3.3 | 3.7 | 3.0 | 2.7 | |
Inventory Days | Days | 52 | 25 | 36 | 9 | 6 | |
Debtors Days | Days | 100,485,142 | 101,414,616 | 991 | 941 | 1,130 | |
Net fixed assets | Rs m | 155 | 215 | 226 | 321 | 795 | |
Share capital | Rs m | 90 | 90 | 100 | 120 | 125 | |
"Free" reserves | Rs m | 249 | 332 | 400 | 496 | 764 | |
Net worth | Rs m | 338 | 422 | 500 | 616 | 889 | |
Long term debt | Rs m | 2 | 22 | 0 | 0 | 309 | |
Total assets | Rs m | 413 | 553 | 606 | 770 | 1,437 | |
Interest coverage | x | 43.5 | 26.0 | 191.4 | 124.3 | 195.7 | |
Debt to equity ratio | x | 0 | 0.1 | 0 | 0 | 0.3 | |
Sales to assets ratio | x | 0.9 | 1.2 | 0.8 | 0.9 | 0.6 | |
Return on assets | % | 15.6 | 19.9 | 16.2 | 17.6 | 11.9 | |
Return on equity | % | 18.4 | 24.8 | 19.5 | 21.8 | 19.1 | |
Return on capital | % | 26.0 | 31.8 | 26.0 | 29.5 | 18.9 | |
Exports to sales | % | 70.4 | 73.4 | 74.6 | 63.9 | 68.6 | |
Imports to sales | % | 21.2 | 30.9 | 23.1 | 13.1 | 23.7 | |
Exports (fob) | Rs m | 249 | 470 | 366 | 455 | 619 | |
Imports (cif) | Rs m | 75 | 198 | 113 | 93 | 213 | |
Fx inflow | Rs m | 249 | 470 | 366 | 455 | 619 | |
Fx outflow | Rs m | 75 | 198 | 113 | 93 | 213 | |
Net fx | Rs m | 173 | 272 | 253 | 362 | 405 |
SHREE GANESH REMEDIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -52 | 46 | 33 | 134 | 170 | |
From Investments | Rs m | -1 | -29 | -9 | -119 | -536 | |
From Financial Activity | Rs m | -2 | -5 | -7 | -11 | 413 | |
Net Cashflow | Rs m | -55 | 12 | 17 | 4 | 48 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Chandubhai Kothia | COMP SEC: Aditya Patel | YEAR OF INC: 1995 | BSE CODE: 540737 | FV (Rs): 10 | DIV YIELD (%): 0.1 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SHREE GANESH REMEDIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.